Orthofix Medical (OFIX) Competitors

Orthofix Medical (NASDAQ:OFIX) and AtriCure (NASDAQ:ATRC) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, dividends, institutional ownership, profitability, valuation and community ranking.

Which has better earnings and valuation, OFIX or ATRC?

AtriCure has lower revenue, but higher earnings than Orthofix Medical. AtriCure is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Orthofix Medical	$799.49M	0.81	-$151.40M	-$3.29	-5.16
AtriCure	$465.31M	4.09	-$44.70M	-$0.95	-41.01

Is OFIX or ATRC more profitable?

AtriCure has a net margin of -9.61% compared to Orthofix Medical's net margin of -15.18%. AtriCure's return on equity of -6.80% beat Orthofix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Orthofix Medical	-15.18%	-21.25%	-13.29%
AtriCure	-9.61%	-6.80%	-5.19%

Which has more risk & volatility, OFIX or ATRC?

Orthofix Medical has a beta of 1.1, indicating that its share price is 10% more volatile than the S&P 500. Comparatively, AtriCure has a beta of 1.46, indicating that its share price is 46% more volatile than the S&P 500.

Do insiders & institutionals have more ownership in OFIX or ATRC?

89.8% of Orthofix Medical shares are owned by institutional investors. Comparatively, 99.1% of AtriCure shares are owned by institutional investors. 2.6% of Orthofix Medical shares are owned by insiders. Comparatively, 3.2% of AtriCure shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Do analysts rate OFIX or ATRC?

Orthofix Medical presently has a consensus price target of $23.33, suggesting a potential upside of 37.42%. AtriCure has a consensus price target of $51.56, suggesting a potential upside of 32.33%. Given Orthofix Medical's higher possible upside, analysts plainly believe Orthofix Medical is more favorable than AtriCure.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Orthofix Medical	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.80
AtriCure	0 Sell rating(s)	0 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the MarketBeat Community favor OFIX or ATRC?

AtriCure received 151 more outperform votes than Orthofix Medical when rated by MarketBeat users. Likewise, 69.47% of users gave AtriCure an outperform vote while only 62.20% of users gave Orthofix Medical an outperform vote.

Company	Underperform	Outperform
Orthofix Medical	Outperform Votes 418 62.20%	Underperform Votes 254 37.80%
AtriCure	Outperform Votes 569 69.47%	Underperform Votes 250 30.53%

Does the media favor OFIX or ATRC?

In the previous week, Orthofix Medical had 20 more articles in the media than AtriCure. MarketBeat recorded 24 mentions for Orthofix Medical and 4 mentions for AtriCure. AtriCure's average media sentiment score of 1.64 beat Orthofix Medical's score of 0.05 indicating that AtriCure is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Orthofix Medical	2 Very Positive mention(s)	4 Positive mention(s)	10 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral
AtriCure	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

AtriCure beats Orthofix Medical on 14 of the 18 factors compared between the two stocks.